Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.3205
+0.0035 (1.10%)
May 5, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Life-transforming Therapies
636.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
636.00K